Skip to main content
Top
Published in: Pathology & Oncology Research 1/2009

01-03-2009 | Original Paper

INCENP (Inner Centromere Protein) is Overexpressed in High Grade Non-Hodgkin B-cell Lymphomas

Authors: Sotirios Barbanis, Maria Ioannou, Evangelos Kouvaras, Foteini Karasavvidou, Marianna Nakou, Roidoula Papamichali, George Koukoulis

Published in: Pathology & Oncology Research | Issue 1/2009

Login to get access

Abstract

Inner centromere protein (INCENP) is a member of the Chromosomal Passenger Complex (CPC), which is a four member protein complex essential for proper completion of mitosis and cell division (cytokinesis). Inappropriate chromosomal segregation and cytokinesis due to deregulated expression of chromosome passenger proteins may lead to aneuploidy and cancer including lymphomas. According to our knowledge this is the first study investigating immunohistochemical expression of INCENP in lymphoma cases and cancer tissues in general. Our purpose was to characterize the expression of INCENP in cases of non-Hodgkin B-cell lymphomas, to compare the immunoreactivity between low and high grades and to evaluate the correlation between INCENP and MIB-1 labeling indices. We examined INCENP and MIB-1 immunoreactivity in paraffin sections of 55 samples of non-Hodgkin B-cell lymphomas, obtained from 55 patients, 31 men and 24 women. Thirty were of high grade and 25 were of low grade. Our results showed significantly higher nuclear immunohistochemical expression of INCENP in high grade B-cell lymphomas versus low grade ones. Also INCENP expression was significantly correlated with MIB-1 labeling index. Taken together our results point to a possible association between increased INCENP immunostaining and B-cell lymphoma aggressiveness and also stress the need for further investigating the expression of INCENP and other mitotic regulatory proteins in lymphomas and other malignant neoplasms.
Literature
1.
go back to reference Ruchaud S, Carmena M, Earnshaw WC (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8:798–812PubMedCrossRef Ruchaud S, Carmena M, Earnshaw WC (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8:798–812PubMedCrossRef
2.
go back to reference Vader G, Medema RH, Lens SM (2006) The chromosomal passenger complex: guiding Aurora-B through mitosis. J Cell Biol 173:833–837PubMedCrossRef Vader G, Medema RH, Lens SM (2006) The chromosomal passenger complex: guiding Aurora-B through mitosis. J Cell Biol 173:833–837PubMedCrossRef
3.
go back to reference Klein UR, Nigg EA, Gruneberg U (2006) Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Mol Biol Cell 17:2547–2558PubMedCrossRef Klein UR, Nigg EA, Gruneberg U (2006) Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Mol Biol Cell 17:2547–2558PubMedCrossRef
4.
go back to reference Cooke CA, Heck MM, Earnshaw WC (1987) The inner centromere protein (INCENP) antigens: movement from inner centromere to midbody during mitosis. J Cell Biol 105:2053–2067PubMedCrossRef Cooke CA, Heck MM, Earnshaw WC (1987) The inner centromere protein (INCENP) antigens: movement from inner centromere to midbody during mitosis. J Cell Biol 105:2053–2067PubMedCrossRef
5.
go back to reference Sessa F, Mapelli M, Ciferri C et al (2005) Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Mol Cell 18:379–391PubMedCrossRef Sessa F, Mapelli M, Ciferri C et al (2005) Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Mol Cell 18:379–391PubMedCrossRef
7.
go back to reference Adams RR, Eckley DM, Vagnarelli P et al (2001) Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells. Chromosoma 110:65–74PubMedCrossRef Adams RR, Eckley DM, Vagnarelli P et al (2001) Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells. Chromosoma 110:65–74PubMedCrossRef
8.
go back to reference Cutts SM, Fowler KJ, Kile BT et al (1999) Defective chromosome segregation, microtubule bundling and nuclear bridging in inner centromere protein gene (Incenp)-disrupted mice. Hum Mol Genet 8:1145–1155PubMedCrossRef Cutts SM, Fowler KJ, Kile BT et al (1999) Defective chromosome segregation, microtubule bundling and nuclear bridging in inner centromere protein gene (Incenp)-disrupted mice. Hum Mol Genet 8:1145–1155PubMedCrossRef
9.
go back to reference Nguyen HG, Ravid K (2006) Tetraploidy/aneuploidy and stem cells in cancer promotion: the role of chromosome passenger proteins. J Cell Physiol 208:12–22PubMedCrossRef Nguyen HG, Ravid K (2006) Tetraploidy/aneuploidy and stem cells in cancer promotion: the role of chromosome passenger proteins. J Cell Physiol 208:12–22PubMedCrossRef
11.
go back to reference Wheatley SP, Carvalho A, Vagnarelli P, Earnshaw WC (2001) INCENP is required for proper targeting of survivin to the centromeres and the anaphase spindle during mitosis. Curr Biol 11:886–890PubMedCrossRef Wheatley SP, Carvalho A, Vagnarelli P, Earnshaw WC (2001) INCENP is required for proper targeting of survivin to the centromeres and the anaphase spindle during mitosis. Curr Biol 11:886–890PubMedCrossRef
12.
go back to reference Gerlach U, Kayser G, Walch A et al (2006) Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. J Pathol 208:462–472PubMedCrossRef Gerlach U, Kayser G, Walch A et al (2006) Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. J Pathol 208:462–472PubMedCrossRef
13.
go back to reference Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC, Lyon Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC, Lyon
14.
go back to reference Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with imageJ. Biophoton Int 11:36–42 Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with imageJ. Biophoton Int 11:36–42
16.
go back to reference Pérez de Castro I, de Cárcer G, Malumbres M (2007) A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28:899–912PubMedCrossRef Pérez de Castro I, de Cárcer G, Malumbres M (2007) A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28:899–912PubMedCrossRef
17.
go back to reference Storchova Z, Pellman D (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45–54PubMedCrossRef Storchova Z, Pellman D (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45–54PubMedCrossRef
18.
go back to reference Altieri DC (2003) Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5:447–452PubMed Altieri DC (2003) Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5:447–452PubMed
19.
go back to reference Mainou-Fowler T, Overman LM, Dignum H et al (2008) A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2. Int J Oncol 32:59–68PubMed Mainou-Fowler T, Overman LM, Dignum H et al (2008) A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2. Int J Oncol 32:59–68PubMed
21.
go back to reference Kajiwara Y, Yamasaki F, Hama S et al (2003) Expression of survivin in astrocytic tumors: Correlation with malignant grade and prognosis. Cancer 97:1077–1083PubMedCrossRef Kajiwara Y, Yamasaki F, Hama S et al (2003) Expression of survivin in astrocytic tumors: Correlation with malignant grade and prognosis. Cancer 97:1077–1083PubMedCrossRef
22.
go back to reference Li F (2005) Role of survivin and its splice variants in tumorigenesis. Br J Cancer 92:212–216PubMed Li F (2005) Role of survivin and its splice variants in tumorigenesis. Br J Cancer 92:212–216PubMed
23.
go back to reference Araki K, Nozaki K, Ueba T, Tatsuka M, Hashimoto N (2004) High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J Neurooncol 67:53–64PubMedCrossRef Araki K, Nozaki K, Ueba T, Tatsuka M, Hashimoto N (2004) High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J Neurooncol 67:53–64PubMedCrossRef
24.
go back to reference Sorrentino R, Libertini S, Pallante Pl et al (2005) Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 90:928–935PubMedCrossRef Sorrentino R, Libertini S, Pallante Pl et al (2005) Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 90:928–935PubMedCrossRef
25.
go back to reference Sistayanarain A, Tsuneyama K, Zheng H et al (2006) Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma. Anticancer Res 26:585–593 Sistayanarain A, Tsuneyama K, Zheng H et al (2006) Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma. Anticancer Res 26:585–593
26.
go back to reference Chieffi P, Cozzolino L, Kisslinger A et al (2006) Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66:326–333PubMedCrossRef Chieffi P, Cozzolino L, Kisslinger A et al (2006) Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66:326–333PubMedCrossRef
27.
go back to reference Chang JL, Chen TH, Wang CF et al (2006) Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer. Exp Cell Res 312:962–973PubMedCrossRef Chang JL, Chen TH, Wang CF et al (2006) Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer. Exp Cell Res 312:962–973PubMedCrossRef
28.
go back to reference Miller TP, Grogan TM, Dahlberg S et al (1994) Prognostic significance of the Ki-67-assosiated proliferative antigen in aggressive non-Hodgkin’s lymphomas: a prospective Southwest Oncology Group trial. Blood 83:1460–1466PubMed Miller TP, Grogan TM, Dahlberg S et al (1994) Prognostic significance of the Ki-67-assosiated proliferative antigen in aggressive non-Hodgkin’s lymphomas: a prospective Southwest Oncology Group trial. Blood 83:1460–1466PubMed
29.
go back to reference Petit B, Chaury MP, Le Clorennec C et al (2005) Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki-67 expression identifies a better prognostic subgroup. Haematologica 90:200–206PubMed Petit B, Chaury MP, Le Clorennec C et al (2005) Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki-67 expression identifies a better prognostic subgroup. Haematologica 90:200–206PubMed
30.
go back to reference Lehman NL, Tibshirani R, Hsu JY et al (2007) Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am J Pathol 170:1793–1805PubMedCrossRef Lehman NL, Tibshirani R, Hsu JY et al (2007) Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am J Pathol 170:1793–1805PubMedCrossRef
Metadata
Title
INCENP (Inner Centromere Protein) is Overexpressed in High Grade Non-Hodgkin B-cell Lymphomas
Authors
Sotirios Barbanis
Maria Ioannou
Evangelos Kouvaras
Foteini Karasavvidou
Marianna Nakou
Roidoula Papamichali
George Koukoulis
Publication date
01-03-2009
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2009
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-008-9094-0

Other articles of this Issue 1/2009

Pathology & Oncology Research 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine